Latest On ADMA Biologics, Inc (ADMA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-11 01:31 EST | News | ADMA Biologics GAAP EPS of -$0.03 beats by $0.01, revenue of $57M beats by $3.59M | N/A |  |
| 2023-05-11 01:30 EST | News | ADMA Biologics, Inc. (ADMA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 23:31 EST | News | ADMA Biologics Q1 2023 Earnings Preview | N/A | |
| 2023-03-30 00:16 EST | News | ADMA Biologics: Growth Trends Pointing To Profitability | N/A | |
| 2023-03-24 06:16 EST | News | ADMA Biologics GAAP EPS of -$0.06 beats by $0.01, revenue of $49.95M beats by $1.88M | N/A | |
| 2023-03-24 06:16 EST | News | ADMA Biologics expects first-time positive EBITDA by second half of year | N/A | |
| 2023-03-24 06:15 EST | News | ADMA Biologics, Inc. (ADMA) Q4 2022 Earnings Call Transcript | N/A | |
| 2023-03-22 23:00 EST | News | ADMA Biologics Q4 2022 Earnings Preview | N/A | |
| 2023-02-08 18:02 EST | News | ADMA Biocenters receives FDA approval for eighth plasma collection center | N/A | |
| 2023-01-17 17:02 EST | News | ADMA Biologics gains as guidance exceeds consensus | N/A | |
| 2023-01-15 06:00 EST | News | ADMA Biologics: FY22 Numbers Key Inflection Point | N/A | |
| 2022-12-13 19:01 EST | News | Adma gets FDA approval for room temperature storage of Asceniv, Bivigam | N/A | |
| 2022-12-08 03:17 EST | News | ADMA Biologics stock dips after pricing ~$60M share offering | N/A | |
| 2022-12-07 07:16 EST | News | ADMA Biologics down 7% following stock offering | N/A | |
| 2022-11-11 05:31 EST | News | ADMA Biologics hits 52-week high after strong Q3 beat | N/A | |
| 2022-11-09 19:31 EST | News | ADMA Biologics GAAP EPS of -$0.08 in-line, revenue of $41.09M beats by $6.61M | N/A | |
| 2022-11-09 19:30 EST | News | ADMA Biologics, Inc. (ADMA) Q3 2022 Earnings Call Transcript | N/A | |
| 2022-11-09 01:31 EST | News | ADMA Biologics Q3 2022 Earnings Preview | N/A | |
| 2022-10-31 13:46 EST | News | Adma stock rises on FDA approval of North Carolina-based plasma collection center | N/A | |
| 2022-10-24 18:01 EST | News | Adma Biologics: Understanding The Risks Of Blood Plasma Collection | N/A | |
| 2022-08-22 16:50 EST | News | ADMA Biologics: Strong Growth Is Clearing The Path To Profitability | N/A | |
| 2022-08-11 22:17 EST | News | ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-11 22:16 EST | News | Adma stock rises 10% after Q2 revenue nearly doubles, net loss narrows | N/A | |
| 2022-08-11 05:31 EST | News | ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M | N/A | |
| 2022-08-11 05:30 EST | News | ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-08-09 17:45 EST | News | ADMA Biologics Q2 2022 Earnings Preview | N/A | |
| 2022-06-27 23:02 EST | News | ADMA's 6th plasma collection facility gets FDA approval | N/A | |
| 2022-06-21 22:02 EST | News | ADMA biologics to enter Russell 2000 index | N/A | |
| 2022-05-13 06:31 EST | News | ADMA Biologics: A Path To Profits Looks Clear | N/A | |
| 2022-05-12 11:47 EST | News | ADMA Biologics, Inc.'s (ADMA) CEO Adam Grossman on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-11 18:00 EST | News | ADMA Biologics GAAP EPS of -$0.13 misses by $0.04, revenue of $29.1M beats by $0.95M | N/A | |
| 2022-05-11 18:00 EST | News | ADMA Biologics up 4% after increasing 2022 revenue guidance | N/A | |
| 2022-05-10 22:45 EST | News | ADMA Biologics Q1 2022 Earnings Preview | N/A | |
| 2022-04-19 02:16 EST | News | ADMA: Pertinent Updates | N/A | |
| 2022-04-04 13:21 EST | News | ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-29 21:17 EST | News | ADMA Biologics' 2021 Numbers Showed Continued Strong Execution | N/A | |
| 2022-03-25 12:19 EST | News | ADMA Biologics GAAP EPS of -$0.09 beats by $0.01, revenue of $26.38M beats by $4.61M | N/A | |
| 2022-03-25 12:19 EST | News | ADMA Biologics up in after-hours trading following quarterly top and bottom line beats | N/A | |
| 2022-03-25 12:18 EST | News | ADMA Biologics gets FDA approval to extend shelf life of Asceniv, Bivigam | N/A | |
| 2022-03-24 02:33 EST | News | ADMA Biologics Q4 2021 Earnings Preview | N/A | |
| 2022-02-10 22:16 EST | News | Adma Biologics activist said to support strategic review | N/A | |
| 2022-01-19 08:15 EST | News | ADMA biologics expects record preliminary 4Q and FY21 revenues to be above the consensus | N/A | |
| 2022-01-18 16:46 EST | News | ADMA Biologics wins FDA nod for its fourth plasma collection center | N/A | |
| 2022-01-18 16:46 EST | News | ADMA Biologics: 2021 Was Tough | N/A | |
| 2021-12-28 22:16 EST | News | FDA updates EUA for COVID convalescent plasma limiting use to certain patients | N/A | |
| 2021-12-09 15:17 EST | News | ADMA Biologics secures new European patent related to S. pneumonia infections | N/A | |
| 2021-11-20 23:16 EST | News | ADMA Biologics: Turning A Corner | N/A | |
| 2021-11-11 20:31 EST | News | ADMA Biologics raised to Strong Buy at Raymond James citing financial momentum | N/A | |
| 2021-11-11 00:15 EST | News | ADMA Biologics, Inc. (ADMA) CEO Adam Grossman on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-10 01:31 EST | News | ADMA Biologics Q3 2021 Earnings Preview | N/A | |
About ADMA Biologics, Inc (ADMA):
ADMA Biologics, Inc., a biopharmaceutical and specialty immunoglobulin company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States. It offers BIVIGAM, an intravenous immune globulin product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company distributes its products through independent distributors, sales agents, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.
General
- Name ADMA Biologics, Inc
- Symbol ADMA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 313
- Fiscal Year EndDecember
- IPO Date2013-10-17
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.admabiologics.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 5.32
- Price/Book (Most Recent Quarter) 3.7
- Enterprise Value Revenue 7.55
View More
Financials
- Most Recent Quarter 2020-09-30
- Next Quarter EPS Estimate -$0.17
- Profit Margin -166%
- Operating Margin -138%
- Return on Assets -21%
- Return on Equity -124%
- Revenue 40.3 million
- Earnings Per Share -$1.24
- Revenue Per Share $0.53
- Gross Profit -10155155
- Quarterly Earnings Growth 42.3%
View More
Highlights
- Market Capitalization 195.71 million
- EBITDA -52103768
- Analyst Target Price $8.83
- Book Value Per Share $0.80
View More
Share Statistics
- Shares Outstanding 94.55 million
- Shares Float 76.07 million
- % Held by Insiders 213%
- % Held by Institutions 54.51%
- Shares Short 8.18 million
- Shares Short Prior Month 8.75 million
- Short Ratio 1.91
- Short % of Float 12%
- Short % of Shares Outstanding 9%
View More
Technicals
- Beta 1.7
- 52 Week High $4.2
- 52 Week Low $1.73
- 50 Day Moving Average 2.42
- 200 Day Moving Average 2.23
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
ADMA Biologics, Inc (ADMA) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
ADMA Biologics, Inc (ADMA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-09-30 | 2020-11-05 | $N/A | -$0.19 | -$0.20 | 4.04% |
| 2020-06-30 | 2020-08-05 | $N/A | -$0.23 | -$0.16 | -42.24% |
| 2020-03-31 | 2020-05-06 | $N/A | -$0.26 | -$0.11 | -128.07% |
| 2019-12-31 | 2020-03-12 | $12.04 million | -$0.18 | -$0.18 | -0.95% |
| 2019-09-30 | 2019-11-06 | $7.22 million | -$0.19 | -$0.23 | 15.56% |
| 2019-06-30 | 2019-08-08 | $6.56 million | -$0.25 | -$0.29 | 14.65% |
| 2019-03-31 | 2019-05-08 | $3.53 million | -$0.28 | -$0.32 | 11.39% |
| 2018-12-31 | 2019-03-13 | $4.06 million | -$0.39 | -$0.33 | -17.15% |
| 2018-09-30 | 2018-11-08 | $4.23 million | -$0.33 | -$0.31 | -6.45% |
| 2018-06-30 | 2018-08-10 | $4.66 million | -$0.35 | -$0.31 | -11.86% |
| 2018-03-31 | 2018-05-14 | $4.04 million | -$0.39 | -$0.31 | -26.83% |
| 2017-12-31 | 2018-03-05 | $12 million | -$0.24 | -$0.39 | 38.46% |
| 2017-09-30 | 2017-11-03 | $4.73 million | -$0.59 | -$0.50 | -18.59% |
| 2017-06-30 | 2017-08-11 | $3.4 million | -$0.55 | -$0.30 | -84.87% |
| 2017-03-31 | 2017-05-12 | $2.63 million | -$0.51 | -$0.28 | -80.53% |
| 2016-12-31 | 2017-02-24 | $3.33 million | -$0.34 | -$0.32 | -5.59% |
| 2016-09-30 | 2016-11-10 | $2.94 million | -$0.34 | -$0.41 | 17.87% |
| 2016-06-30 | 2016-08-12 | $2.27 million | -$0.50 | -$0.38 | -30.89% |
| 2016-03-31 | 2016-05-13 | $2.12 million | -$0.43 | -$0.44 | 2.82% |
| 2015-12-31 | 2016-03-23 | $2.51 million | -$0.44 | -$0.45 | 2.22% |
| 2015-09-30 | 2015-11-10 | $1.85 million | -$0.48 | -$0.39 | -23.08% |
| 2015-06-30 | 2015-08-11 | $1.31 million | -$0.44 | -$0.35 | -25.71% |
| 2015-03-31 | 2015-05-12 | $1.5 million | -$0.37 | -$0.38 | 2.63% |
| 2014-12-31 | 2015-03-09 | $1.49 million | -$0.38 | -$0.38 | 0% |
| 2014-09-30 | 2014-11-10 | $1.37 million | -$0.36 | -$0.37 | 2.7% |
| 2014-06-30 | 2014-08-11 | $1.5 million | -$0.43 | -$0.52 | 17.31% |
| 2014-03-31 | 2014-05-12 | $1.56 million | -$0.64 | -$0.49 | -30.61% |
| 2013-12-31 | 2014-03-28 | $425000 | -$0.54 | -$0.47 | -14.89% |
| 2013-09-30 | 2013-11-12 | $1.11 million | -$0.29 |
ADMA Biologics, Inc (ADMA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
ADMA Biologics, Inc (ADMA) Chart:
ADMA Biologics, Inc (ADMA) News:
Below you will find a list of latest news for ADMA Biologics, Inc (ADMA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
ADMA Biologics, Inc (ADMA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | 1 | 0 | CALL | 0 | 15 | 210.81 | TRUE | 0 | 0 |
| 2026-11-20 | 2 | 0 | CALL | 0 | 10 | 119.52 | TRUE | 0 | 0 |
| 2026-11-20 | 3 | 0 | CALL | 0 | 1 | 87.12 | TRUE | 0 | 0 |
| 2026-11-20 | 4 | 0 | CALL | 0 | 0 | 64.5 | TRUE | 0 | 0 |
| 2026-11-20 | 5 | 0 | CALL | 0 | 20 | 64.59 | TRUE | 0 | 0 |
| 2026-11-20 | 6 | 0 | CALL | 0 | 0 | 64.45 | TRUE | 0 | 0 |
| 2026-11-20 | 7 | 0 | CALL | 0 | 16 | 74.26 | TRUE | 0 | 0 |
| 2026-11-20 | 8 | 0 | CALL | 0 | 5 | 73.08 | TRUE | 0 | 0 |
| 2026-11-20 | 9 | 1.51 | CALL | 9 | 139 | 67.26 | TRUE | 0.21 | 0.16 |
| 2026-11-20 | 10 | 0 | CALL | 0 | 112 | 57.68 | FALSE | 0 | 0 |
| 2026-11-20 | 11 | 0.7 | CALL | 32 | 13036 | 87.13 | FALSE | 0.7 | 0 |
| 2026-11-20 | 12 | 0.05 | CALL | 2 | 94 | 57.99 | FALSE | 0.05 | 0 |
| 2026-11-20 | 13 | 0.22 | CALL | 0 | 4108 | 78.32 | FALSE | 0 | 0 |
| 2026-11-20 | 14 | 0 | CALL | 0 | 563 | 82.49 | FALSE | 0 | 0 |
| 2026-11-20 | 15 | 0 | CALL | 0 | 968 | 60.14 | FALSE | 0 | 0 |
| 2026-11-20 | 16 | 0 | CALL | 0 | 3003 | 118.44 | FALSE | 0 | 0 |
| 2026-11-20 | 17 | 0 | CALL | 0 | 2 | 103.36 | FALSE | 0 | 0 |
| 2026-11-20 | 18 | 0 | CALL | 0 | 207 | 84.63 | FALSE | 0 | 0 |
| 2026-11-20 | 19 | 0 | CALL | 0 | 8 | 121.27 | FALSE | 0 | 0 |
| 2026-11-20 | 20 | 0 | CALL | 0 | 10 | 109.91 | FALSE | 0 | 0 |
| 2026-11-20 | 21 | 0 | CALL | 0 | 2 | 84.99 | FALSE | 0 | 0 |
| 2026-11-20 | 22 | 0 | CALL | 0 | 1 | 107.2 | FALSE | 0 | 0 |
| 2026-11-20 | 23 | 0 | CALL | 0 | 0 | 122.5 | FALSE | 0 | 0 |
| 2026-11-20 | 24 | 0 | CALL | 0 | 0 | 95.25 | FALSE | 0 | 0 |
| 2026-11-20 | 25 | 0 | CALL | 0 | 11 | 117.9 | FALSE | 0 | 0 |
| 2026-11-20 | 1 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2026-11-20 | 2 | 0 | PUT | 0 | 0 | 434.78 | FALSE | 0 | 0 |
| 2026-11-20 | 3 | 0 | PUT | 0 | 0 | 266.67 | FALSE | 0 | 0 |
| 2026-11-20 | 4 | 0 | PUT | 0 | 35 | 191.66 | FALSE | 0 | 0 |
| 2026-11-20 | 5 | 0 | PUT | 0 | 11 | 143.69 | FALSE | 0 | 0 |
| 2026-11-20 | 6 | 0 | PUT | 0 | 3038 | 121.05 | FALSE | 0 | 0 |
| 2026-11-20 | 7 | 0 | PUT | 0 | 126 | 67.3 | FALSE | 0 | 0 |
| 2026-11-20 | 8 | 0.85 | PUT | 0 | 5846 | 57.66 | FALSE | 0 | 0 |
| 2026-11-20 | 9 | 0 | PUT | 0 | 39 | 84.43 | FALSE | 0 | 0 |
| 2026-11-20 | 10 | 0 | PUT | 0 | 101 | 65.67 | TRUE | 0 | 0 |
| 2026-11-20 | 11 | 0 | PUT | 0 | 12 | 68.83 | TRUE | 0 | 0 |
| 2026-11-20 | 12 | 0 | PUT | 0 | 16 | 76.16 | TRUE | 0 | 0 |
| 2026-11-20 | 13 | 0 | PUT | 0 | 24 | 65.36 | TRUE | 0 | 0 |
| 2026-11-20 | 14 | 0 | PUT | 0 | 20 | 61.6 | TRUE | 0 | 0 |
| 2026-11-20 | 15 | 0 | PUT | 0 | 1 | 63.06 | TRUE | 0 | 0 |
| 2026-11-20 | 16 | 0 | PUT | 0 | 0 | 99.5 | TRUE | 0 | 0 |
| 2026-11-20 | 17 | 0 | PUT | 0 | 1 | 106.2 | TRUE | 0 | 0 |
| 2026-11-20 | 18 | 0 | PUT | 0 | 0 | 112.37 | TRUE | 0 | 0 |
| 2026-11-20 | 19 | 0 | PUT | 0 | 0 | 118.12 | TRUE | 0 | 0 |
| 2026-11-20 | 20 | 0 | PUT | 0 | 0 | 97.07 | TRUE | 0 | 0 |
| 2026-11-20 | 21 | 0 | PUT | 0 | 0 | 112.2 | TRUE | 0 | 0 |
| 2026-11-20 | 22 | 0 | PUT | 0 | 0 | 88.19 | TRUE | 0 | 0 |
| 2026-11-20 | 23 | 0 | PUT | 0 | 0 | 121.02 | TRUE | 0 | 0 |
| 2026-11-20 | 24 | 0 | PUT | 0 | 0 | 125.1 | TRUE | 0 | 0 |
| 2026-11-20 | 25 | 0 | PUT | 0 | 0 | 128.98 | TRUE | 0 | 0 |
| 2027-01-15 | 3 | 0 | CALL | 0 | 166 | 73.98 | TRUE | 0 | 0 |
| 2027-01-15 | 5 | 4.3 | CALL | 0 | 52 | 66.91 | TRUE | 0 | 0 |
| 2027-01-15 | 6 | 0 | CALL | 0 | 1 | 76.78 | TRUE | 0 | 0 |
| 2027-01-15 | 7 | 0 | CALL | 0 | 82 | 55.1 | TRUE | 0 | 0 |
| 2027-01-15 | 8 | 0 | CALL | 0 | 181 | 46.67 | TRUE | 0 | 0 |
| 2027-01-15 | 9 | 0 | CALL | 0 | 87 | 81.23 | TRUE | 0 | 0 |
| 2027-01-15 | 10 | 1.5 | CALL | 5 | 961 | 62.1 | FALSE | 0.3 | 0.25 |
| 2027-01-15 | 11 | 0 | CALL | 0 | 24 | 68.84 | FALSE | 0 | 0 |
| 2027-01-15 | 12 | 0.6 | CALL | 6 | 29 | 58.01 | FALSE | 0.6 | 0 |
| 2027-01-15 | 13 | 0.55 | CALL | 20 | 2232 | 52.91 | FALSE | 0.55 | 0 |
| 2027-01-15 | 14 | 0 | CALL | 0 | 61 | 97.92 | FALSE | 0 | 0 |
| 2027-01-15 | 15 | 0.3 | CALL | 5 | 1364 | 61.18 | FALSE | 0.03 | 0.11 |
| 2027-01-15 | 16 | 0 | CALL | 0 | 58 | 109.88 | FALSE | 0 | 0 |
| 2027-01-15 | 17 | 0 | CALL | 0 | 645 | 85.96 | FALSE | 0 | 0 |
| 2027-01-15 | 20 | 0.07 | CALL | 5 | 3203 | 65.36 | FALSE | 0.07 | 0 |
| 2027-01-15 | 22 | 0 | CALL | 0 | 545 | 71.42 | FALSE | 0 | 0 |
| 2027-01-15 | 25 | 0 | CALL | 0 | 719 | 111.33 | FALSE | 0 | 0 |
| 2027-01-15 | 27 | 0 | CALL | 0 | 3469 | 83.92 | FALSE | 0 | 0 |
| 2027-01-15 | 30 | 0 | CALL | 0 | 469 | 96.77 | FALSE | 0 | 0 |
| 2027-01-15 | 32 | 0 | CALL | 0 | 22 | 100.64 | FALSE | 0 | 0 |
| 2027-01-15 | 35 | 0 | CALL | 0 | 166 | 105.93 | FALSE | 0 | 0 |
| 2027-01-15 | 37 | 0 | CALL | 0 | 44 | 112.19 | FALSE | 0 | 0 |
| 2027-01-15 | 3 | 0 | PUT | 0 | 0 | 255.19 | FALSE | 0 | 0 |
| 2027-01-15 | 5 | 0 | PUT | 0 | 17 | 87.64 | FALSE | 0 | 0 |
| 2027-01-15 | 6 | 0 | PUT | 0 | 5 | 126.52 | FALSE | 0 | 0 |
| 2027-01-15 | 7 | 0 | PUT | 0 | 14 | 104.09 | FALSE | 0 | 0 |
| 2027-01-15 | 8 | 0 | PUT | 0 | 123 | 63.43 | FALSE | 0 | 0 |
| 2027-01-15 | 9 | 0 | PUT | 0 | 182 | 71.58 | FALSE | 0 | 0 |
| 2027-01-15 | 10 | 0 | PUT | 0 | 94 | 76.81 | TRUE | 0 | 0 |
| 2027-01-15 | 11 | 0 | PUT | 0 | 2 | 63.46 | TRUE | 0 | 0 |
| 2027-01-15 | 12 | 0 | PUT | 0 | 0 | 65.61 | TRUE | 0 | 0 |
| 2027-01-15 | 13 | 0 | PUT | 0 | 1081 | 62.87 | TRUE | 0 | 0 |
| 2027-01-15 | 14 | 0 | PUT | 0 | 0 | 62.27 | TRUE | 0 | 0 |
| 2027-01-15 | 15 | 0 | PUT | 0 | 345 | 74.49 | TRUE | 0 | 0 |
| 2027-01-15 | 16 | 0 | PUT | 0 | 0 | 71.48 | TRUE | 0 | 0 |
| 2027-01-15 | 17 | 0 | PUT | 0 | 37 | 76.81 | TRUE | 0 | 0 |
| 2027-01-15 | 20 | 0 | PUT | 0 | 0 | 103.37 | TRUE | 0 | 0 |
| 2027-01-15 | 22 | 0 | PUT | 0 | 0 | 111.59 | TRUE | 0 | 0 |
| 2027-01-15 | 25 | 0 | PUT | 0 | 0 | 109 | TRUE | 0 | 0 |
| 2027-01-15 | 27 | 0 | PUT | 0 | 0 | 115.21 | TRUE | 0 | 0 |
| 2027-01-15 | 30 | 0 | PUT | 0 | 0 | 137.43 | TRUE | 0 | 0 |
| 2027-01-15 | 32 | 0 | PUT | 0 | 0 | 128.69 | TRUE | 0 | 0 |
| 2027-01-15 | 35 | 0 | PUT | 0 | 0 | 135.74 | TRUE | 0 | 0 |
| 2027-01-15 | 37 | 0 | PUT | 0 | 0 | 147.71 | TRUE | 0 | 0 |
| 2027-02-19 | 1 | 0 | CALL | 0 | 0 | 145.26 | TRUE | 0 | 0 |
| 2027-02-19 | 2 | 0 | CALL | 0 | 0 | 87.89 | TRUE | 0 | 0 |
| 2027-02-19 | 3 | 0 | CALL | 0 | 0 | 63.88 | TRUE | 0 | 0 |
| 2027-02-19 | 4 | 0 | CALL | 0 | 0 | 68.74 | TRUE | 0 | 0 |
| 2027-02-19 | 5 | 0 | CALL | 0 | 1 | 127.74 | TRUE | 0 | 0 |
| 2027-02-19 | 6 | 0 | CALL | 0 | 0 | 70.07 | TRUE | 0 | 0 |
| 2027-02-19 | 7 | 0 | CALL | 0 | 0 | 51.65 | TRUE | 0 | 0 |
| 2027-02-19 | 8 | 0 | CALL | 0 | 2 | 51.59 | TRUE | 0 | 0 |
| 2027-02-19 | 9 | 0 | CALL | 0 | 0 | 70.1 | TRUE | 0 | 0 |
| 2027-02-19 | 10 | 0 | CALL | 0 | 0 | 73.35 | FALSE | 0 | 0 |
| 2027-02-19 | 11 | 0 | CALL | 0 | 0 | 80.35 | FALSE | 0 | 0 |
| 2027-02-19 | 12 | 0 | CALL | 0 | 0 | 81.66 | FALSE | 0 | 0 |
| 2027-02-19 | 13 | 0.52 | CALL | 1 | 5 | 61.87 | FALSE | 0.52 | 0 |
| 2027-02-19 | 14 | 0 | CALL | 0 | 0 | 62.04 | FALSE | 0 | 0 |
| 2027-02-19 | 15 | 0 | CALL | 0 | 1 | 71.18 | FALSE | 0 | 0 |
| 2027-02-19 | 16 | 0 | CALL | 0 | 0 | 97.36 | FALSE | 0 | 0 |
| 2027-02-19 | 17 | 0 | CALL | 0 | 0 | 105.39 | FALSE | 0 | 0 |
| 2027-02-19 | 1 | 0 | PUT | 0 | 0 | 585.39 | FALSE | 0 | 0 |
| 2027-02-19 | 2 | 0 | PUT | 0 | 0 | 231.49 | FALSE | 0 | 0 |
| 2027-02-19 | 3 | 0 | PUT | 0 | 0 | 229.37 | FALSE | 0 | 0 |
| 2027-02-19 | 4 | 0 | PUT | 0 | 0 | 177.28 | FALSE | 0 | 0 |
| 2027-02-19 | 5 | 0 | PUT | 0 | 0 | 151.25 | FALSE | 0 | 0 |
| 2027-02-19 | 6 | 0 | PUT | 0 | 0 | 93.24 | FALSE | 0 | 0 |
| 2027-02-19 | 7 | 0 | PUT | 0 | 0 | 78.79 | FALSE | 0 | 0 |
| 2027-02-19 | 8 | 0 | PUT | 0 | 10 | 70.11 | FALSE | 0 | 0 |
| 2027-02-19 | 9 | 0 | PUT | 0 | 0 | 75.41 | FALSE | 0 | 0 |
| 2027-02-19 | 10 | 0 | PUT | 0 | 1 | 67.73 | TRUE | 0 | 0 |
| 2027-02-19 | 11 | 0 | PUT | 0 | 0 | 60.4 | TRUE | 0 | 0 |
| 2027-02-19 | 12 | 0 | PUT | 0 | 0 | 64.54 | TRUE | 0 | 0 |
| 2027-02-19 | 13 | 0 | PUT | 0 | 0 | 80.69 | TRUE | 0 | 0 |
| 2027-02-19 | 14 | 0 | PUT | 0 | 0 | 62.95 | TRUE | 0 | 0 |
| 2027-02-19 | 15 | 0 | PUT | 0 | 0 | 66.63 | TRUE | 0 | 0 |
| 2027-02-19 | 16 | 0 | PUT | 0 | 3 | 66.65 | TRUE | 0 | 0 |
| 2027-02-19 | 17 | 0 | PUT | 0 | 0 | 71.61 | TRUE | 0 | 0 |
| 2028-01-21 | 3 | 0 | CALL | 0 | 184 | 41.07 | TRUE | 0 | 0 |
| 2028-01-21 | 5 | 5.3 | CALL | 3 | 132 | 68.18 | TRUE | 5.3 | 0 |
| 2028-01-21 | 8 | 3.6 | CALL | 1 | 302 | 67.46 | TRUE | 0.3 | 0.09 |
| 2028-01-21 | 10 | 2.95 | CALL | 1 | 1791 | 62.61 | FALSE | 2.95 | 0 |
| 2028-01-21 | 13 | 1.75 | CALL | 0 | 282 | 60.81 | FALSE | 0 | 0 |
| 2028-01-21 | 15 | 1.2 | CALL | 0 | 276 | 47.19 | FALSE | 0 | 0 |
| 2028-01-21 | 17 | 0 | CALL | 0 | 112 | 70.41 | FALSE | 0 | 0 |
| 2028-01-21 | 20 | 0 | CALL | 0 | 254 | 54.43 | FALSE | 0 | 0 |
| 2028-01-21 | 22 | 0 | CALL | 0 | 143 | 57.04 | FALSE | 0 | 0 |
| 2028-01-21 | 25 | 0.4 | CALL | 0 | 253 | 66.97 | FALSE | 0 | 0 |
| 2028-01-21 | 27 | 0 | CALL | 0 | 19 | 88.09 | FALSE | 0 | 0 |
| 2028-01-21 | 30 | 0 | CALL | 0 | 38 | 91.93 | FALSE | 0 | 0 |
| 2028-01-21 | 35 | 0 | CALL | 0 | 17 | 125.05 | FALSE | 0 | 0 |
| 2028-01-21 | 3 | 0 | PUT | 0 | 0 | 166.21 | FALSE | 0 | 0 |
| 2028-01-21 | 5 | 0 | PUT | 0 | 0 | 106.27 | FALSE | 0 | 0 |
| 2028-01-21 | 8 | 0 | PUT | 0 | 29 | 70.26 | FALSE | 0 | 0 |
| 2028-01-21 | 10 | 0 | PUT | 0 | 257 | 46.33 | TRUE | 0 | 0 |
| 2028-01-21 | 13 | 0 | PUT | 0 | 171 | 45.04 | TRUE | 0 | 0 |
| 2028-01-21 | 15 | 0 | PUT | 0 | 16 | 54.32 | TRUE | 0 | 0 |
| 2028-01-21 | 17 | 0 | PUT | 0 | 100 | 53.15 | TRUE | 0 | 0 |
| 2028-01-21 | 20 | 0 | PUT | 0 | 4 | 62.44 | TRUE | 0 | 0 |
| 2028-01-21 | 22 | 0 | PUT | 0 | 1 | 67.79 | TRUE | 0 | 0 |
| 2028-01-21 | 25 | 0 | PUT | 0 | 0 | 61.52 | TRUE | 0 | 0 |
| 2028-01-21 | 27 | 0 | PUT | 0 | 0 | 65.54 | TRUE | 0 | 0 |
| 2028-01-21 | 30 | 0 | PUT | 0 | 0 | 71.07 | TRUE | 0 | 0 |
| 2028-01-21 | 35 | 0 | PUT | 0 | 0 | 79.24 | TRUE | 0 | 0 |
Latest ADMA Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 38 | $1.905 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.905 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.905 |
| Jun 13, 2022 7:59 PM EST | 36 | $1.905 |
| Jun 13, 2022 7:59 PM EST | 100 | $1.9 |
ADMA Biologics, Inc (ADMA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm |
| 2019-10-09 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1368514/000000000019014431/0000000000-19-014431-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000083423720008032/0000834237-20-008032-index.htm |
| 2020-03-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000083423720009209/0000834237-20-009209-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm |
| 2020-03-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000091957419001192/0000919574-19-001192-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000091957420001141/0000919574-20-001141-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000108514619000734/0001085146-19-000734-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000108514620000752/0001085146-20-000752-index.htm |
| 2019-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm |
| 2019-06-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1368514/000112329219000869/0001123292-19-000869-index.htm |
| 2020-04-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1368514/000114036120010160/0001140361-20-010160-index.htm |
| 2020-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1368514/000114036120010161/0001140361-20-010161-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000119312519040961/0001193125-19-040961-index.htm |
| 2019-05-23 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000119312519154707/0001193125-19-154707-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1368514/000119312520038101/0001193125-20-038101-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001175/0001193805-18-001175-index.htm |
| 2018-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001198/0001193805-18-001198-index.htm |
| 2018-10-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001210/0001193805-18-001210-index.htm |
| 2018-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001238/0001193805-18-001238-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001316/0001193805-18-001316-index.htm |
| 2018-11-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001319/0001193805-18-001319-index.htm |
| 2018-12-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001425/0001193805-18-001425-index.htm |
| 2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001429/0001193805-18-001429-index.htm |
| 2018-12-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380518001431/0001193805-18-001431-index.htm |
| 2019-01-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000012/0001193805-19-000012-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000026/0001193805-19-000026-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000090/0001193805-19-000090-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000091/0001193805-19-000091-index.htm |
| 2019-01-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000092/0001193805-19-000092-index.htm |
| 2019-01-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000098/0001193805-19-000098-index.htm |
| 2019-02-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000160/0001193805-19-000160-index.htm |
| 2019-02-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000246/0001193805-19-000246-index.htm |
| 2019-02-27 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000251/0001193805-19-000251-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000254/0001193805-19-000254-index.htm |
| 2019-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000280/0001193805-19-000280-index.htm |
| 2019-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000281/0001193805-19-000281-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000292/0001193805-19-000292-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000293/0001193805-19-000293-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000294/0001193805-19-000294-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000295/0001193805-19-000295-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000296/0001193805-19-000296-index.htm |
| 2019-03-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000297/0001193805-19-000297-index.htm |
| 2019-03-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000301/0001193805-19-000301-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000332/0001193805-19-000332-index.htm |
| 2019-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000339/0001193805-19-000339-index.htm |
| 2019-04-05 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000346/0001193805-19-000346-index.htm |
| 2019-04-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000366/0001193805-19-000366-index.htm |
| 2019-04-24 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000415/0001193805-19-000415-index.htm |
| 2019-05-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000441/0001193805-19-000441-index.htm |
| 2019-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000454/0001193805-19-000454-index.htm |
| 2019-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000455/0001193805-19-000455-index.htm |
| 2019-05-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000470/0001193805-19-000470-index.htm |
| 2019-05-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000490/0001193805-19-000490-index.htm |
| 2019-05-15 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000492/0001193805-19-000492-index.htm |
| 2019-05-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000496/0001193805-19-000496-index.htm |
| 2019-05-17 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000498/0001193805-19-000498-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm |
| 2019-05-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm |
| 2019-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000525/0001193805-19-000525-index.htm |
| 2019-05-29 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000540/0001193805-19-000540-index.htm |
| 2019-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000559/0001193805-19-000559-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000561/0001193805-19-000561-index.htm |
| 2019-06-12 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000569/0001193805-19-000569-index.htm |
| 2019-07-01 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000614/0001193805-19-000614-index.htm |
| 2019-07-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000621/0001193805-19-000621-index.htm |
| 2019-07-16 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000637/0001193805-19-000637-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000714/0001193805-19-000714-index.htm |
| 2019-08-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000715/0001193805-19-000715-index.htm |
| 2019-08-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000761/0001193805-19-000761-index.htm |
| 2019-08-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000774/0001193805-19-000774-index.htm |
| 2019-09-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000798/0001193805-19-000798-index.htm |
| 2019-09-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000839/0001193805-19-000839-index.htm |
| 2019-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000887/0001193805-19-000887-index.htm |
| 2019-10-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000893/0001193805-19-000893-index.htm |
| 2019-10-04 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000903/0001193805-19-000903-index.htm |
| 2019-10-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000905/0001193805-19-000905-index.htm |
| 2019-10-07 | 424B7 | Prospectus [Rule 424(b)(7)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000907/0001193805-19-000907-index.htm |
| 2019-10-10 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001327/0001193805-19-001327-index.htm |
| 2019-10-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001351/0001193805-19-001351-index.htm |
| 2019-10-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001355/0001193805-19-001355-index.htm |
| 2019-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001361/0001193805-19-001361-index.htm |
| 2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001396/0001193805-19-001396-index.htm |
| 2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001398/0001193805-19-001398-index.htm |
| 2019-11-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001423/0001193805-19-001423-index.htm |
| 2019-11-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001461/0001193805-19-001461-index.htm |
| 2019-12-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380519001941/0001193805-19-001941-index.htm |
| 2020-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000010/0001193805-20-000010-index.htm |
| 2020-01-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000024/0001193805-20-000024-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000033/0001193805-20-000033-index.htm |
| 2020-02-06 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000106/0001193805-20-000106-index.htm |
| 2020-02-07 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000109/0001193805-20-000109-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000110/0001193805-20-000110-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm |
| 2020-02-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000138/0001193805-20-000138-index.htm |
| 2020-02-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000139/0001193805-20-000139-index.htm |
| 2020-02-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000259/0001193805-20-000259-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm |
| 2020-03-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm |
| 2020-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000300/0001193805-20-000300-index.htm |
| 2020-03-13 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000348/0001193805-20-000348-index.htm |
| 2020-03-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000349/0001193805-20-000349-index.htm |
| 2020-03-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000377/0001193805-20-000377-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000452/0001193805-20-000452-index.htm |
| 2020-04-13 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000474/0001193805-20-000474-index.htm |
| 2020-04-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000502/0001193805-20-000502-index.htm |
| 2020-04-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000529/0001193805-20-000529-index.htm |
| 2020-05-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000548/0001193805-20-000548-index.htm |
| 2020-05-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000549/0001193805-20-000549-index.htm |
| 2020-05-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000550/0001193805-20-000550-index.htm |
| 2020-05-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000551/0001193805-20-000551-index.htm |
| 2020-05-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000552/0001193805-20-000552-index.htm |
| 2020-05-01 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000553/0001193805-20-000553-index.htm |
| 2020-05-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000561/0001193805-20-000561-index.htm |
| 2020-05-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000562/0001193805-20-000562-index.htm |
| 2020-05-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000618/0001193805-20-000618-index.htm |
| 2020-05-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000638/0001193805-20-000638-index.htm |
| 2020-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000710/0001193805-20-000710-index.htm |
| 2020-06-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000712/0001193805-20-000712-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000713/0001193805-20-000713-index.htm |
| 2020-07-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000770/0001193805-20-000770-index.htm |
| 2020-08-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000957/0001193805-20-000957-index.htm |
| 2020-08-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000960/0001193805-20-000960-index.htm |
| 2020-08-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000961/0001193805-20-000961-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm |
| 2020-08-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm |
| 2020-08-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm |
| 2020-08-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm |
| 2020-08-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm |
| 2020-09-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001111/0001193805-20-001111-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm |
| 2020-09-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001390/0001193805-20-001390-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001392/0001193805-20-001392-index.htm |
| 2020-11-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001393/0001193805-20-001393-index.htm |
| 2019-10-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1368514/999999999519002318/9999999995-19-002318-index.htm |
| 2018-09-24 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1368514/999999999718008174/9999999997-18-008174-index.htm |
| 2019-04-16 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/1368514/999999999719002962/9999999997-19-002962-index.htm |
| 2020-02-03 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1368514/999999999720000431/9999999997-20-000431-index.htm |
| 2020-02-10 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/1368514/999999999720000623/9999999997-20-000623-index.htm |
ADMA Biologics, Inc (ADMA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ADMA Biologics, Inc (ADMA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 213%Institutional Ownership: 5451%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2019-05-17 | Jerrold B Grossman | Director | Buy | 12,000.00 | 4.00 | 48,000.00 | 110,007.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000524/0001193805-19-000524-index.htm |
| 2019-05-21 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 4,000,000.00 | 4.00 | 16,000,000.00 | 11,521,102.00 | https://www.sec.gov/Archives/edgar/data/1368514/000089924319014466/0000899243-19-014466-index.htm |
| 2020-02-11 | Jerrold B Grossman | Director | Buy | 22,857.00 | 3.50 | 79,999.50 | 132,864.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm |
| 2020-02-28 | Jerrold B Grossman | Director | Buy | 7,500.00 | 140,364.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000288/0001193805-20-000288-index.htm | ||
| 2020-08-12 | Jerrold B Grossman | Director | Buy | 200.00 | 2.87 | 574.00 | 140,564.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm |
| 2020-08-12 | Jerrold B Grossman | Director | Buy | 5,000.00 | 2.89 | 14,450.00 | 145,564.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm |
| 2020-08-12 | Jerrold B Grossman | Director | Buy | 5,000.00 | 2.90 | 14,475.00 | 150,564.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001023/0001193805-20-001023-index.htm |
| 2020-08-21 | Jerrold B Grossman | Director | Buy | 5,000.00 | 2.56 | 12,800.00 | 155,564.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm |
| 2020-08-21 | Jerrold B Grossman | Director | Buy | 300.00 | 2.62 | 786.00 | 155,864.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001069/0001193805-20-001069-index.htm |
| 2020-02-11 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 4,563,700.00 | 3.50 | 15,972,950.00 | 16,084,802.00 | https://www.sec.gov/Archives/edgar/data/1368514/000089924320003914/0000899243-20-003914-index.htm |
| 2020-09-10 | Jerrold B Grossman | Director | Buy | 5,000.00 | 2.22 | 11,100.00 | 160,864.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001135/0001193805-20-001135-index.htm |
| 2020-03-19 | PERCEPTIVE ADVISORS LLC | 10% Share Holder | Buy | 500,000.00 | 2.10 | 1,050,000.00 | 16,584,802.00 | https://www.sec.gov/Archives/edgar/data/1368514/000089924320009225/0000899243-20-009225-index.htm |
| 2020-02-28 | Adam S Grossman | President and CEO | Buy | 100,000.00 | 166,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000287/0001193805-20-000287-index.htm | ||
| 2020-08-10 | Adam S Grossman | President and CEO | Buy | 10.00 | 3.06 | 30.60 | 166,108.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm |
| 2020-08-10 | Adam S Grossman | President and CEO | Buy | 2,990.00 | 3.07 | 9,179.30 | 169,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm |
| 2020-08-10 | Adam S Grossman | President and CEO | Buy | 2,000.00 | 3.04 | 6,080.00 | 171,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm |
| 2020-08-11 | Adam S Grossman | President and CEO | Buy | 1,000.00 | 2.97 | 2,970.00 | 172,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001005/0001193805-20-001005-index.htm |
| 2020-09-08 | Adam S Grossman | President and CEO | Buy | 4,000.00 | 2.24 | 8,959.60 | 176,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001128/0001193805-20-001128-index.htm |
| 2019-05-17 | James Mond | EVP, CSO and CMO | Buy | 4,500.00 | 4.00 | 18,000.00 | 17,889.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000522/0001193805-19-000522-index.htm |
| 2020-08-13 | MARTHA J DEMSKI | Director | Buy | 2,000.00 | 2.88 | 5,760.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001036/0001193805-20-001036-index.htm |
| 2020-02-11 | James Mond | CSO and CMO | Buy | 4,285.00 | 3.50 | 14,997.50 | 22,174.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000133/0001193805-20-000133-index.htm |
| 2020-02-11 | Jerrold B Grossman | Director | Buy | 22,857.00 | 3.50 | 79,999.50 | 22,857.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000131/0001193805-20-000131-index.htm |
| 2019-05-17 | BRIAN LENZ | EVP, CFO | Buy | 5,000.00 | 4.00 | 20,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000521/0001193805-19-000521-index.htm |
| 2020-02-11 | BRIAN LENZ | EVP, CFO | Buy | 7,142.00 | 3.50 | 24,997.00 | 32,142.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000129/0001193805-20-000129-index.htm |
| 2019-05-17 | Adam S Grossman | President and CEO | Buy | 5,000.00 | 4.00 | 20,000.00 | 37,527.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm |
| 2020-09-11 | MARTHA J DEMSKI | Director | Buy | 2,200.00 | 2.29 | 5,038.00 | 4,200.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001139/0001193805-20-001139-index.htm |
| 2019-06-06 | Biotest Divestiture Trust | 10% Share Holder | Sell | 5,813,954.00 | 3.75 | 21,802,327.50 | 4,295,580.00 | https://www.sec.gov/Archives/edgar/data/1368514/000112329219000868/0001123292-19-000868-index.htm |
| 2020-02-28 | ERIC I RICHMAN | Director | Buy | 7,500.00 | 44,030.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000290/0001193805-20-000290-index.htm | ||
| 2019-05-17 | Lawrence P. Guiheen | Director | Buy | 25,000.00 | 4.00 | 100,000.00 | 50,000.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000523/0001193805-19-000523-index.htm |
| 2020-02-28 | James Mond | EVP, CSO and CMO | Buy | 40,000.00 | 62,174.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000285/0001193805-20-000285-index.htm | ||
| 2020-02-11 | Adam S Grossman | President and CEO | Buy | 28,571.00 | 3.50 | 99,998.50 | 66,098.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm |
| 2020-08-10 | James Mond | EVP, CSO and CMO | Buy | 5,000.00 | 2.88 | 14,400.00 | 67,174.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm |
| 2020-08-10 | James Mond | EVP, CSO and CMO | Buy | 2,000.00 | 2.88 | 5,750.00 | 69,174.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001003/0001193805-20-001003-index.htm |
| 2020-02-11 | Lawrence P. Guiheen | Director | Buy | 20,000.00 | 3.50 | 70,000.00 | 70,000.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000135/0001193805-20-000135-index.htm |
| 2020-02-28 | BRIAN LENZ | EVP, CFO | Buy | 40,000.00 | 72,142.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000286/0001193805-20-000286-index.htm | ||
| 2020-09-08 | James Mond | EVP, CSO and CMO | Buy | 4,000.00 | 2.20 | 8,800.00 | 73,174.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001129/0001193805-20-001129-index.htm |
| 2020-02-28 | Bryant Fong | Director | Buy | 7,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000293/0001193805-20-000293-index.htm | ||
| 2020-02-28 | DOV A MD GOLDSTEIN | Director | Buy | 7,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000291/0001193805-20-000291-index.htm | ||
| 2020-02-28 | STEVE ELMS | Director | Buy | 7,500.00 | 7,500.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000292/0001193805-20-000292-index.htm | ||
| 2020-08-11 | BRIAN LENZ | EVP, CFO | Buy | 4,000.00 | 2.97 | 11,860.00 | 76,142.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520001004/0001193805-20-001004-index.htm |
| 2020-02-28 | Lawrence P. Guiheen | Director | Buy | 7,500.00 | 77,500.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000289/0001193805-20-000289-index.htm | ||
| 2019-05-17 | Adam S Grossman | President and CEO | Buy | 25,000.00 | 4.00 | 100,000.00 | 821,301.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380519000520/0001193805-19-000520-index.htm |
| 2020-02-11 | Adam S Grossman | President and CEO | Buy | 57,143.00 | 3.50 | 200,000.50 | 878,444.00 | https://www.sec.gov/Archives/edgar/data/1368514/000119380520000127/0001193805-20-000127-index.htm |